PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Biopharmaceutical Research, West China Hospital, Sichuan University, Chengdu 610041, China.\', \'National Engineering Research Center of Immunological Products, Army Medical University, Chongqing 400038, China.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3760/cma.j.cn112150-20200317-00366
?:hasPublicationType
?:journal
  • Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
is ?:pmid of
?:pmid
?:pmid
  • 32234130
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.19
?:rankingScore_hIndex
  • 23
is ?:relation_isRelatedTo_publication of
?:title
  • [Progress and challenge of vaccine development against 2019-novel coronavirus (2019-nCoV)].
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32234130>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32234130>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all